Heidelberg Pharma AG
F:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
Kao Corp
F:KAO
|
JP |
Multiples-Based Value
The Multiples-Based Value for
Heidelberg Pharma AG (HPHA) under the Base Case is 2.19 EUR.
Compared with the current market price of 2.56 EUR, the stock appears
Overvalued by 14% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.